17th Annual ASHP Conference for Leaders in Health-System Pharmacy

Similar documents
Agenda. Learning Objectives 1) Describe health care imperative changes and impact on pharmacy practice

Ambulatory Care Practice Trends and Opportunities in Pharmacy

The Role of Pharmacy in Alternative Payment Models

THE BEST OF TIMES: PHARMACY IN AN ERA OF

Specialty Pharmacy: What You Need To Know. William Pong, Pharm.D., MBA

Seeing the Value and Transparency of Medicare Part B: Four Case Studies of Medicare Successes

TKG Health Systems Advisory Panel Meeting. Healthcare in 2017: Trends & Hot Topics. Tuesday, March 24 th, 2017 Gaylord Texan Resort, Grapevine, TX

WHITE PAPER. The Shift to Value-Based Care: 9 Steps to Readiness.

Hospital Readmissions Survival Guide

Connected Care Partners

The Case for Home Care Medicine: Access, Quality, Cost

PPMI in a Community Teaching Hospital

04/08/2015. Thinking Beyond the Hospital Walls: Readmission Reduction Strategies for Pharmacists. Pharmacist Objectives. Technician Objectives

Implementing Medicaid Value-Based Purchasing Initiatives with Federally Qualified Health Centers

Creating the future. Celebrating the past. Learning Objectives. Disclosure. How Provider Status, PAI, and YOU Can Impact the Future of Pharmacy

Primary Care Transformation in the Era of Value

HEALTHCARE 20/20: LEARNING FORWARD

Performance Measurement of a Pharmacist-Directed Anticoagulation Management Service

ARRA HEALTH IT INCENTIVES - UNCERTAINTIES ABOUT "MEANINGFUL USE"

Pharmacy Leadership and Administration Learning Experience Rev 12/16/16

Outcomes Measurement in Long-Term Care (LTC)

Saint Francis Care and Cigna CAC Meeting the Triple Aim Together

State Leadership for Health Care Reform

Health Care Evolution

WELCOME. Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association

THE NATIONAL QUALITY MEASUREMENT AND IMPROVEMENT AGENDA

Hospital Readmissions

Transitioning to a Value-Based Accountable Health System Preparing for the New Business Model. The New Accountable Care Business Model

F O R G R E AT E R H E A LT H

Remaking Health Care in America

Click to edit Master title style

MTM Performance & Impact On Star Ratings 2016 & Beyond - OutcomesMTM Overview

Reducing the High Cost of Patient Non-Adherence:

THE NEW IMPERATIVE: WHY HEALTHCARE ORGANIZATIONS ARE SEEKING TRANSFORMATIONAL CHANGE AND HOW THEY CAN ACHIEVE IT

UPDATE ON MEANINGFUL USE. HITECH Stimulus Act of 2009: CSC Point of View

The Physician s Perspective

W. Douglas Weaver, MD, MACC. American College of Cardiology SENATE FINANCE COMMITTEE

The U.S. Healthcare Revolution

Health Policy Update 2017: The Evolution of Physician Payment. Declarations. Agenda 10/11/2017. Revised

Volume to Value Transition in the USA

kaiser medicaid and the uninsured commission on O L I C Y

Evolving Roles of Pharmacists: Integrating Medication Management Services

Thinking Outside the Box: Pharmacists Role in Ambulatory Care

Interoperability is Happening Now

Physician Alignment Strategies and Options. June 1, 2011

Is Audiology effected by the Changes or will it be?

Future of Patient Safety and Healthcare Quality

Succeeding with Accountable Care Organizations

UAMS/SVI Partnership Agreement. Proposal

The influx of newly insured Californians through

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

Medicare Advocacy in Regulatory Changes and Trends

HEALTH CARE REFORM IN THE U.S.

Here is what we know. Here is what you can do. Here is what we are doing.

The Journey to Meaningful Use: Where we were, where we are, and where we may be going

Shana Scott, JD, MPH, Health Systems Team Lead Tuesday, October 3, 2017

Impact of an Innovative ADC System on Medication Administration

SPECIALTY PHARMACY TAMING SPECIALTY DRUG COSTS FOR SELF- INSURED HEALTH PLANS

Specialty Pharmacy and the Vulnerable Patient from the Health-System Perspective

Specialty Pharmacy How is Traditional Pharmacy Practice Positioned

Advanced Use of Health Information Technology to Support New Models of Care

8/27/2015. Background Overview Overarching Themes & Highlights of the Proposed Rule Areas of Concern Submitting Comments Resources Questions

1. What are the requirements for Stage 1 of the HITECH Act for CPOE to qualify for incentive payments?

Optimizing pharmaceutical care via Health Information Technology:

Health Information Technology

Objectives. Assisted Living. O 2 : Opportunities & Outcomes in Assisted Living. Presented by: Chief Clinical Officer

ENHANCING PRESCRIBER RELATIONSHIPS: MAKING IT A WIN-WIN JULY 12, :00 5:00 PM

HOW WILL MINORITY-SERVING HOSPITALS FARE UNDER THE ACA?

Medicare & Medicaid EHR Incentive Program Specifics of the Program for Hospitals. August 11, 2010

The Alternative Quality Contract (AQC): Improving Quality While Slowing Spending Growth

Providing and Billing Medicare for Transitional Care Management

End-to-end infusion safety. Safely manage infusions from order to administration

American Recovery & Reinvestment Act

Banner Health Friday, February 20, 2015

Overview of the EHR Incentive Program Stage 2 Final Rule published August, 2012

August 15, Dear Mr. Slavitt:

CAHPS Focus on Improvement The Changing Landscape of Health Care. Ann H. Corba Patient Experience Advisor Press Ganey Associates

Expansion of Pharmacy Services within Patient Centered Medical Homes. Jeremy Thomas, PharmD Associate Professor Department Pharmacy Practice

New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report

Innovative Business Activities in Health Care with Commercial Partners

10/1/ OBRA Doctor of Pharmacy as entry-level degree Medication Therapy Management (MTM) 2010-ACA signed into law

Roadmap for Transforming America s Health Care System

Adopting a Care Coordination Strategy

HIMSS DFW ADVOCACY. Overview THIS ISSUE CONTRIBUTE. Why is Advocacy important?

The Evolution of ASC Joint Ventures: Key Trends for Value-Based Care

eprescribing Information to Improve Medication Adherence

From 2009 to 2012, the total change in net operating revenue among all hospitals was 3.3%, with an average annual change of 1.1%.

Population Health Management Tools and Strategies to Support Care Coordination An InfoMC White Paper April 2016

Physician Compensation in an Era of New Reimbursement Models

The HITECH EHR "Meaningful Use" Requirements for Hospitals and Eligible Professionals

Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy

U.S. Healthcare Problem

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None

What Have we Learned from the Pioneer ACO Model?

Value-Based Payments 101: Moving from Volume to Value in Behavioral Health Care

Overall Learning Objectives How large is the specialty pharmaceutical market? Drug Trends Source: CVS Caremark 2013 Drug Trend Focus Report

CMS-0044-P; Proposed Rule: Medicare and Medicaid Programs; Electronic Health Record Incentive Program Stage 2

Cultural Transformation and the Road to an ACO Lee Sacks, M.D. CEO Mark Shields, M.D., MBA Senior Medical Director

New pharmacy practice opportunity: Enhancement of the transitions of care process

Pharmacy Management. 450 Pharmacy Management Positions

Transcription:

17th Annual ASHP Conference for Leaders in Health-System Pharmacy Lee Vermeulen, M.S., B.S.Pharm., FCCP Health Care Transitions: What Trends Are Next for the Front-line Leader? Activity Overview Pharmacy strategic planning is intertwined with health system planning and regulatory and legislative changes. What forces are driving competitive health systems in today s health care market? Learn what macro trends in health care are being forecasted and what is new with health care reform trends that should drive your pharmacy enterprise planning. Learning Objectives After participating in this application-based educational activity, participants should be able to Define specific areas of health policy, health finance, technology, and pharmacy practice that will influence the future of health system pharmacy. List resources that health system pharmacy leaders should monitor to remain aware of emerging trends. Prepare individual and organizational plans that respond to future changes with the intent of managing the impact of those changes. 1

Leading the Pharmacy Enterprise: Advancing Practice with Transitions in Health Care Health Care Transitions: What Trends Are Next for the Front-line Leader? Lee Vermeulen, M.S., B.S.Pharm., FCCP University of Wisconsin - Madison Madison, Wisconsin Disclaimers Influence of perspective on views regarding the future Individual filter Past personal experiences World view Organizational filter My crystal ball is probably no better than yours Overarching Leadership Challenge Fast pace of change, pace increasing Rapid flow of information Heightened expectation of responsiveness Diminished confidence in assumptions and estimates lower value of gut instinct Stakes are higher than ever before Overwhelmed? Distinguish reaction from response 2

Reaction Impossible to recognize implications of change Uncertainty destroys confidence and leads to indecision and higher likelihood of failure Difficult to get ahead of the curve once behind Response Collect Information What are you reading? Who are you talking to? What are you paying attention to? Interpret Information Implications? Respond Plan Prioritize Act Monitor Overarching Recommendations Invest time in reading, thinking, and planning Read and listen with intent to plan Rely on training, inherent skill set Temper skepticism How can we capitalize IF trend is real? Do not get caught in identity trap Few trends are unimportant for pharmacy Keep your feet moving and stay nimble 3

Key Areas to Monitor Policy Finance Technology Practice Distinction among areas somewhat arbitrary great deal of overlap between areas Policy tied to finance, finance tied to technology, etc. Trends in Health Policy (1) U.S. Health Care Expenditures as Percent of GDP, 2011-2020 Centers for Medicare & Medicaid Services. National health expenditure projections 2011-2021 (URL in ref list). Trends in Health Policy (2) Affordable Care Act S/P SCOTUS decision Individual mandate upheld Medicaid expansion overturned, but growth still likely as Fed paying the bill and can leverage via exchange subsidy changes S/P Election Repeal unlikely; too much already done in commercial sector to turn back now Changes likely, regardless of outcome 4

Donabedian Conundrum COST Goal of ACA = Reduce cost HOW??? QUALITY ACCESS Goal of ACA = Improve quality Goal of ACA = Increase access Trends in Health Policy (3) FDA reform Especially in device arena More active monitoring of safety, s/p REMS HIPAA reform Privacy vs. Technology of Patient Experience (Paul Ellwood 1988 Shattuck Lecture) Patent reform Legislative attempts to alleviate drug shortages Trends in Health Care Finance (1) Almost all health care policy reform is driven by changes to payment Growth in cost of health care has reached unsustainable point Bubble Expenditures, both public and private, will decrease Diminishing potential for thoughtful approach to determining level and distribution of expenditures that are reasonable, fair, just 5

Trends in Drug Expenditures 1998-2011 However, growth in cost of medications has moderated in recent years Clinic (triangle) Total (diamonds) Hospital (squares) Hoffman JM et al. Am J Health-Syst Pharm. 2012; 69:405-21. Trends in Health Care Finance (2) Accountable Care Organizations Major driver of cost savings under ACA Shared savings (i.e., reimbursement will decrease less as an ACO than if not an ACO) Requires very different sort of relationship between hospital-based care and ambulatory care Break-down of cost and quality silos Referral relationships Medication reconciliation on steroids Trends in Health Care Finance (3) Value-based reimbursement on the rise Focus on readmission rates Pay-for-performance; connecting quality to payment Link to process measures currently; future will absolutely shift to meaningful outcome measures 6

Trends in Health Care Finance (4) Health Information Technology for Economic and Clinical Health Act (HITECH) Payment for expanded deployment of electronic health records Meaningful use focused attention on deriving actual value from application of EHR to population health Future payments questionable; at risk as cost savings from ACA become more clear Trends in Health Care Technology (1) Genomics Improved diagnostic approach to targeting therapy Eliminate patients who will not respond to tx Target those patients who will respond to tx Guide product selection, dose Avoidance of costly AEs otherwise not preventable Need clinically relevant markers that affect decision making Huge opportunity, but level of pharmacist expertise in molecular biology is lacking Trends in Health Care Technology (2) Cost out of control, areas at risk Oncology care Value equation, cost per unit of outcome, not attractive for many therapy options Societal willingness to pay is at risk Biologic therapies in RA, GI, derm, etc. Cost per patient high and rising Questionable outcomes, high risk Specialty pharmacy model, dissociated from usual care, not sustainable Orphan disease/drug future doubtful 7

Trends in Health Care Technology (3) Biosimilars (generic biologics) on the rise The era of generics upon us PhRMA profits down, R&D suffering Reduction in number of new drug products applicable to large numbers of patients Therapeutic advances in niche markets only Public funding of research decreasing Trends in Health Care Technology (4) Other technology areas to consider Electronic health record technology, especially expansion of clinical decision support Improved communication technology, allowing greater patient involvement in care, higher expectation of patient responsibility Comparative effectiveness research with increased funding, providing better evidence base for decision making Trends in Pharmacy Practice (1) Rise of ambulatory care and especially primary care Central to success of ACA and ACO Patient-centered medical home (PCMH) concept is key Pharmacist role beyond authorizing prescription renewals! Must accept responsibility for care at (or beyond) limits of scope of practice 8

Trends in Pharmacy Practice (2) Prescriptive authority for pharmacists Questionable likelihood of statutory authority Unavoidable necessity for success of ACA Not a question of billing and reimbursement Expertise, skill Established need Lack of alternative strategies Evidence of superiority of outcomes Non-statutory options Future role of the community pharmacist? What Are You Reading? (1) Newspapers, magazines Still the most accessible source of emerging trend information Biomedical journals Key grazing ; focus on NEJM, JAMA, Ann Intern Med, BMJ, various pharmacy journals Health Affairs (www.healthaffairs.org) Key analysis of health policy, data Pink Sheet (FDC Reports) Expensive, but critical for technology news What Are You Reading? (2) Annual expenditure forecast in AJHP FutureScan Annual forecast from AHA, ACHE Key web sources Kaiser Family Foundation (www.kff.org) CMS Innovation Center (http://www.innovations.cms.gov/) 9

What Are You Reading? (3) Pharmacy Forecast 2013-2017: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems Future trends in eight domains that are likely to challenge pharmacy practice leaders Recommendations to guide strategic planning by pharmacy departments Web-based report Official Release Pharmacy Forecast 2013-2017 Midyear Clinical Meeting, Las Vegas Tuesday, December 4, 2012 Mandalay Bay, Banyan C, Level 3, South Convention Center 11:30 a.m. 1:00 p.m. Summary Planning for the future is necessary for success as a leader in health care Surviving change is fine, but leading change is better! Stay current focus attention on how trends will affect health care and pharmacy 10

Trends in Health Policy (1) 20.0% 19.5% 19.0% 18.5% 18.0% 17.5% 17.9% 17.9% 17.8% 17.7% 17.6% 17.7% U.S. Health Care Expenditures as Percent of GDP, 2011-2020 18.2% 18.2% 18.3% 18.4% 18.6% 18.4% 17.8% 17.9% 18.1% 18.8% 19.1% 18.9% 19.5% 19.2% 17.0% 16.5% 16.0% 2011 2013 2015 2017 2019 Prior to ACA With ACA Centers for Medicare & Medicaid Services. National health expenditure projections 2011-2021 (URL in ref list). Trends in Drug Expenditures 1998-2011 However, growth in cost of medications has moderated in recent years Clinic (triangle) Total (diamonds) Hospital (squares) Hoffmann JM et al. Am J Health-Syst Pharm. 2012; 69:405-21. 11

17th Annual ASHP Conference for Leaders in Health-System Pharmacy S E L E C T E D R E F E R E N C E S 1. Centers for Medicare and Medicaid Services. National health expenditure projections 2011-2021, forecast summary and selected tables. https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-andreports/nationalhealthexpenddata/downloads/proj2011pdf.pdf (accessed 2012 Sept 29). 2. Ellwood PM. Outcomes management (presented as the 99th Shattuck Lecture to the Annual Meeting of the Massachusetts Medical Society on May 21, 1988). New Engl J Med. 1988; 318:1549-56. 3. Hoffman JM, Li E, Doloresco F et al. Projecting future drug expenditures--2012. Am J Health-Syst Pharm. 2012; 69:405-21. R E S O U R C E S F O R M O N I T O R I N G T R E N D S Newspapers, magazines Still the most accessible source of emerging trend information Biomedical journals Key grazing New England Journal of Medicine Journal of the American Medical Association Annals of Internal Medicine British Medical Journal Various pharmacy journals Health Affairs (www.healthaffairs.org) Key analysis of health policy, data Pink Sheet (FDC Reports) Expensive, but critical for technology news Annual expenditure forecast in AJHP FutureScan Annual forecast from AHA, ACHE Key web sources Kaiser Family Foundation (www.kff.org) CMS Innovation Center (http://www.innovations.cms.gov/) Pharmacy Forecast 2013-2017: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems Report from the ASHP Foundation Center for Health-System Pharmacy Leadership to be released December 4, 2012, during Midyear Clinical Meeting 12